Azor Tablet, Film Coated
Product Images NDC 0713-0871
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Azor (NDC 0713-0871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2: Probability Of Achieving Diastolic Blood Pressure (dbp) < 90 Mmhg At Week 8 With Locf (Azor 02)
Figure 3: Probability Of Achieving Systolic Blood Pressure (sbp) < 130 Mmhg At Week 8 With Locf (Azor 03)
Figure 4: Probability Of Achieving Diastolic Blood Pressure (dbp) < 80 Mmhg At Week 8 With Locf (Azor 04)
The Structural Formula For Amlodipine Besylate Is Chemically Described As 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate, Monobenzene (Azor 05)
The Structural Formula For Olmesartan Medoxomil Is Chemically Described As 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[p-(o-1h-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, C (Azor 06)
Principal Display Panel Ndc 0713-0870-30 Azor Amlodipine And Olmesartan Medoxomil 5 mg*/ 20 mg 30 Tablets Rx Only (Azor 07)
Principal Display Panel Ndc 0713-0871-30 Azor Amlodipine And Olmesartan Medoxomil 10 mg*/ 20 mg 30 Tablets Rx Only (Azor 08)
Principal Display Panel Ndc 0713-0872-30 Azor Amlodipine And Olmesartan Medoxomil 5 mg*/ 40 mg 30 Tablets Rx Only (Azor 09)
Principal Display Panel Ndc 0713-0873-30 Azor Amlodipine And Olmesartan Medoxomil 10 mg*/ 40 mg 30 Tablets Rx Only (Azor 0a)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.